ctDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer

Silvia Mešinová, Marián Streško, Lukáš Šebest, Vanda Repiská, Ľuboš Danišovič, Regína Lohajová Behulová

Open source

DOI
10.4149/neo_2026_260622n206
Published
2026-10-15
Container
Neoplasma
Publisher
AEPress, s.r.o.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4149/neo_2026_260622n206,
  title = {ctDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer},
  author = {Silvia Mešinová and Marián Streško and Lukáš Šebest and Vanda Repiská and Ľuboš Danišovič and Regína Lohajová Behulová},
  year = {2026},
  journal = {Neoplasma},
  doi = {10.4149/neo_2026_260622n206},
  url = {https://doi.org/10.4149/neo_2026_260622n206}
}

RIS

TY  - JOUR
TI  - ctDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer
AU  - Silvia Mešinová
AU  - Marián Streško
AU  - Lukáš Šebest
AU  - Vanda Repiská
AU  - Ľuboš Danišovič
AU  - Regína Lohajová Behulová
PY  - 2026
JO  - Neoplasma
DO  - 10.4149/neo_2026_260622n206
UR  - https://doi.org/10.4149/neo_2026_260622n206
ER  - 

APA

Mešinová, S., Streško, M., Šebest, L., Repiská, V., Danišovič, Ľ., & Behulová, R. L. (2026). ctDNA retesting to guide anti-EGFR therapy in later-line metastatic colorectal cancer. Neoplasma. https://doi.org/10.4149/neo_2026_260622n206

Source records